TRB Chemedica Competitors and Similar CompaniesClear all
Cosmo Pharmaceuticals's competitors and similar companies include Repligen, Adamed, Swedish Orphan Biovitrum and Noven Pharmaceuticals.
 Cosmo Pharmaceuticals Cosmo Pharmaceuticals is a company that focuses on solutions in the areas of astroenterology and endoscopy. |  Repligen Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems. |  Swedish Orphan Biovitrum Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care. |  Noven Pharmaceuticals Noven Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products. | ||
Founding Date | Founding Date 1997 | Founding Date 1981 | Founding Date 1986 | Founding Date 2010 | Founding Date 1987 |
Type | Type Public | Type Public | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Dublin, IE HQ | Locations Waltham, US HQ Shanghai, CN Jüri, EE Castanet Tolosan, FR Ravensburg, DE Bengaluru, IN Waterford, IE see more | Locations Jersey City, US HQ Miami, US | ||
Employees | Employees 321 | Employees 1,78312% decrease | Employees 1,5502% increase | Employees 1,895 | Employees 951 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 7.7 b | Valuation ($) N/A | Valuation ($) 11.1 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) €104.2m (FY, 2025) | Revenue (est.) $738.3m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) kr28.2b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods €40.4m (FY, 2025) | Cost of goods $352m (FY, 2025) | Cost of goods N/A | Cost of goods kr6.2b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €70.9m (FY, 2025) | Gross profit $386.2m (FY, 2025) | Gross profit N/A | Gross profit kr22b (FY, 2025) | Gross profit N/A |
Net income | Net income (€3.5m) (FY, 2025) | Net income $48.9m (FY, 2025) | Net income N/A | Net income kr476m (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Repligen
HQ
Waltham, US
Employees
1,783↓ 12% decrease
Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems.
View company
Adamed
HQ
Warsaw, PL
Employees
1,550↑ 2% increase
Adamed Group is a pharmaceutical and biotech company.
View companySwedish Orphan Biovitrum
HQ
Solna, SE
Employees
1,895
Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care.
View companyNoven Pharmaceuticals
HQ
Jersey City, US
Noven Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products.
View company